Your browser doesn't support javascript.
loading
Selinexor: A First-in-Class Nuclear Export Inhibitor for Management of Multiply Relapsed Multiple Myeloma.
Peterson, Tim J; Orozco, Jennifer; Buege, Michael.
Affiliation
  • Peterson TJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Orozco J; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Buege M; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ann Pharmacother ; 54(6): 577-582, 2020 06.
Article in En | MEDLINE | ID: mdl-31793336
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasma Cells / Triazoles / Antineoplastic Combined Chemotherapy Protocols / Cell Nucleus / Receptors, Cytoplasmic and Nuclear / Karyopherins / Hydrazines / Multiple Myeloma Type of study: Systematic_reviews Limits: Animals / Female / Humans / Male Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasma Cells / Triazoles / Antineoplastic Combined Chemotherapy Protocols / Cell Nucleus / Receptors, Cytoplasmic and Nuclear / Karyopherins / Hydrazines / Multiple Myeloma Type of study: Systematic_reviews Limits: Animals / Female / Humans / Male Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Country of publication: